Boehringer Ingelheim Pharmaceuticals Inc. et al v. Apotex Inc. et al
| Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and Boehringer Ingelheim Pharma GmbH & Co. KG |
| Apotex Inc. and Apotex Corp. |
| 1:2023cv00685 |
| June 23, 2023 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 30, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 REDACTED VERSION of #2 Complaint, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: #1 Exhibits 1-2)(Dellinger, Megan) |
| Filing 8 STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Remark: Case submitted for routine judicial assignment. (jfm) |
ORAL ORDER granting #1 MOTION to Seal. A redacted version shall be filed within seven days. Ordered by Judge Colm F. Connolly on 6/26/2023. (nmf)
|
| Filing 7 Summonses Issued (please complete the top portion of the form and print out for use/service). (jfm) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. (jfm) |
| Filing 5 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,486,526B2; 10,034,877B2. (jfm) |
| Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 9, 2023. Date of Expiration of Patent: August 5, 2029. |
| Filing 3 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 2 [SEALED] COMPLAINT filed against Apotex Corp., Apotex Inc. ( Filing fee $ 402, receipt number BDEDC-4164905.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: #1 Exhibit 1, #2 Civil Cover Sheet)(jfm) |
| Filing 1 MOTION for Leave to File Complaint Under Seal - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. (Attachments: #1 Text of Proposed Order)(jfm) |
| Remark: Exit electronic copies to Judge, CFC. |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
